News #ECTRIMS2016 – Eye Imaging, Genetics Link Immune Complement Factors to MS Progression #ECTRIMS2016 – Eye Imaging, Genetics Link Immune Complement Factors to MS Progression by Patricia Silva, PhD | September 14, 2016 Share this article: Share article via email Copy article link Genes that encode what are called “complement” immune factors are linked to the breakdown of the retina in multiple sclerosis (MS) patients ā a measure that, in turn, predicts brain damage and loss of eyesight. The study, a joint effort between researchers from Johns Hopkins School of Medicine, Harvard Medical School, and the Broad Institute, was presented at the Young Scientific Investigators Session 1 atĀ the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) 2016 CongressĀ Sept. 14-17 in London. Titled āA network approach to suggest a role of variation in complement pathway genes in retinal atrophy in multiple sclerosis patients,ā the study hadĀ an ambitious approach, in which researchers usedĀ imaging data from eye examinations to identify genes involved in the severity and disease course of MS. The researchers’ findings present new insights into the disease processes that lead to degeneration of the eye and brain tissue in MS patients. While whole-genome analyses have identified more than 100 gene variants associated with an increased risk of developing MS, few genetic factors that affect the severity of the disease have been found. The research team followed 382 MS patients of European descent, and repeatedly measured the thickness of two layers of the patients’ retina, known as the ganglion layer and the inner plexiform layer. To obtainĀ accurate measurements, researchers used a method called optical coherence tomography (OCT) imaging. Patients were followed for an average of 3.5 years, which allowed researchers to model individual disease trajectories. Researchers then performed a genetic analysis, screening for gene variants that were associated to the disease courses. An advanced statistical analysis allowed the team to describe a genetic network composed of 18 genes.Ā It became clear to the team that the network was centered around the complement system ā a part of the immune system that enhances, or complements, the ability of immune cells to perform their job. In particular, a complement factor known as C3 was found to be more strongly associated with a thinning of the retina. “These results suggest potentially a novel role of the complement pathway that may underlie changes in the retina of MS patients and are supported by existing knowledge of the function of complement genes in retinal ganglion cell pathology and in other neurodegenerative diseases,” the researchers wrote in the Congress’s abstract. Print This Page About the Author Patricia Silva, PhD PatrĆcia holds a PhD in medical microbiology and infectious diseases from the Leiden University Medical Center, Netherlands, and completed a postdoctoral research fellowship at the Instituto de Medicina Molecular, Lisbon, Portugal. Her work in academia was mainly focused on molecular biology and the genetic traits of infectious agents such as viruses and parasites. PatrĆcia earned several travel awards to present her work at international scientific meetings. She is a published author of several peer-reviewed science articles. Tags complement system, ECTRIMS2016, imaging, OCT, optical coherence tomography
April 19, 2024 News by Lindsey Shapiro, PhD AAN 2024: Long-term data support early Kesimpta start in relapsing MS
April 18, 2024 Columns by Benjamin Hofmeister Learning how to write a ‘SOAP’ note feels different after an MS diagnosis
April 18, 2024 News by Marisa Wexler, MS AAN 2024: Sustained myelin, nerve cell gains with long-term CNM-Au8